Q1 2016 13F Holders as of 31 Mar 2016
-
Type / Class
-
Equity / ORD SHS
-
Total 13F shares
-
8,845,792
-
Share change
-
+998,573
-
Total reported value
-
$124,897,448
-
Price per share
-
$14.12
-
Number of holders
-
49
-
Value change
-
+$13,613,076
-
Number of buys
-
29
-
Number of sells
-
20
Institutional Holders of NEURODERM LTD - ORD SHS as of Q1 2016
As of 31 Mar 2016,
NEURODERM LTD - ORD SHS was held by
49 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
8,845,792 shares.
The largest 10 holders included
SCOPIA CAPITAL MANAGEMENT LP, Redmile Group, LLC, ACUTA CAPITAL PARTNERS, LLC, venBio Select Advisor LLC, BlackRock Fund Advisors, BAKER BROS. ADVISORS LP, Foresite Capital Management III, LLC, PERCEPTIVE ADVISORS LLC, SENZAR ASSET MANAGEMENT, LLC, and MENORA MIVTACHIM HOLDINGS LTD..
This page lists
49
institutional shareholders reporting positions in this security
for the Q1 2016 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.